Group One Trading, L.P. Agios Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 13,188 shares of AGIO stock, worth $475,691. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,188
Previous 18,420
28.4%
Holding current value
$475,691
Previous $605,000
36.2%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$206 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$175 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$127 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$88.4 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.98B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...